-
1
-
-
0035815437
-
Control of a mucosal challenge and prevention of AIDS by a multi protein DNA/MVA vaccine
-
Amara RR, Villinger F, Altman JD, et al.: Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine. Science 2001;292(5514):69-74.
-
(2001)
Science
, vol.292
, Issue.5514
, pp. 69-74
-
-
Amara, R.R.1
Villinger, F.2
Altman, J.D.3
-
2
-
-
0033766645
-
Control of viremia and prevention of clinical AIDS inrhesus monkeys by cytokine augmented DNA vaccination
-
Barouch DH, Santra S, Schmitz JE, et al.: Control of viremia andpreventionof clinicalAIDS inrhesusmonkeysbycytokineaugmented DNAvaccination. Science 2000;290(5491):486-492.
-
(2000)
Science
, vol.290
, Issue.5491
, pp. 486-492
-
-
Barouch, D.H.1
Santra, S.2
Schmitz, J.E.3
-
3
-
-
33744990609
-
Preserved CD4+central memory T cells and survival in vaccinated SIV-challenged monkeys
-
Letvin NL, Mascola JR, Sun Y, et al.: Preserved CD4+central memory T cells and survival in vaccinated SIV-challenged monkeys. Science 2006;312(5779):1530-1533.
-
(2006)
Science
, vol.312
, Issue.5779
, pp. 1530-1533
-
-
Letvin, N.L.1
Mascola, J.R.2
Sun, Y.3
-
4
-
-
33744902339
-
Vaccine-induced cellular immune responses reduce plasma viral concentrations after repeated low-dose challenge with pathogenic simian immunodeficiency virus SIVmac239
-
Wilson NA, Reed J, Napoe GS, et al.: Vaccine-induced cellular immune responses reduce plasma viral concentrations after repeated low-dose challenge with pathogenic simian immunodeficiency virus SIVmac239. J Virol 2006;80(12): 5875-5885.
-
(2006)
J Virol
, vol.80
, Issue.12
, pp. 5875-5885
-
-
Wilson, N.A.1
Reed, J.2
Napoe, G.S.3
-
5
-
-
29244455769
-
Attenuation of simian immunodeficiency virus SIVmac239 infection by prophylactic immunization with dna and recombinant adenoviral vaccine vectors expressing Gag
-
Casimiro DR, Wang F, Schleif WA, et al.: Attenuation of simian immunodeficiency virus SIVmac239 infection by prophylactic immunization with dna and recombinant adenoviral vaccine vectors expressing Gag. J Virol 2005;79(24): 15547-15555.
-
(2005)
J Virol
, vol.79
, Issue.24
, pp. 15547-15555
-
-
Casimiro, D.R.1
Wang, F.2
Schleif, W.A.3
-
6
-
-
58149267963
-
Immune control of an SIV challenge by a T-cell-based vaccine in rhesus monkeys
-
Liu J, O'Brien KL, Lynch DM, et al.: Immune control of an SIV challenge by a T-cell-based vaccine in rhesus monkeys. Nature 2009;457(7225):87-91.
-
(2009)
Nature
, vol.457
, Issue.7225
, pp. 87-91
-
-
Liu, J.1
O'Brien, K.L.2
Lynch, D.M.3
-
7
-
-
0034093217
-
Comparative efficacy of recombinant modified vaccinia virus Ankara expressing simian immunodeficiency virus (SIV) Gag-Pol and/or Env in macaques challenged with pathogenic SIV
-
Ourmanov I, Brown CR, Moss B, et al.: Comparative efficacy of recombinant modified vaccinia virus Ankara expressing simian immunodeficiency virus (SIV) Gag-Pol and/or Env in macaques challenged with pathogenic SIV. J Virol 2000; 74(6):2740-2751.
-
(2000)
J Virol
, vol.74
, Issue.6
, pp. 2740-2751
-
-
Ourmanov, I.1
Brown, C.R.2
Moss, B.3
-
8
-
-
0033524838
-
Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes
-
Schmitz JE, Kuroda MJ, Santra S, et al.: Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes. Science 1999;283(5403):857-860.
-
(1999)
Science
, vol.283
, Issue.5403
, pp. 857-860
-
-
Schmitz, J.E.1
Kuroda, M.J.2
Santra, S.3
-
9
-
-
0037122719
-
Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity
-
Shiver JW, Fu TM, Chen L, et al.: Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency- virus immunity. Nature 2002;415(6869):331-335.
-
(2002)
Nature
, vol.415
, Issue.6869
, pp. 331-335
-
-
Shiver, J.W.1
Fu, T.M.2
Chen, L.3
-
10
-
-
38149096202
-
Protection of macaques against vaginal SHIV challenge by systemic or mucosal and systemic vaccinations with HIV-envelope
-
Barnett SW, Srivastava IK, Kan E, et al.: Protection of macaques against vaginal SHIV challenge by systemic or mucosal and systemic vaccinations with HIV-envelope. AIDS 2008;22(3):339-348.
-
(2008)
AIDS
, vol.22
, Issue.3
, pp. 339-348
-
-
Barnett, S.W.1
Srivastava, I.K.2
Kan, E.3
-
11
-
-
0035124098
-
Polyvalent envelope glycoprotein vaccine elicits a broader neutralizing antibody response but is unable to provide sterilizing protection against heterologous simian/human immunodeficiency virus infection in pigtailed macaques
-
Cho MW, Kim YB, Lee MK, et al.: Polyvalent envelope glycoprotein vaccine elicits a broader neutralizing antibody response but is unable to provide sterilizing protection against heterologous simian/human immunodeficiency virus infection in pigtailed macaques. J Virol 2001;75(5):2224-2234.
-
(2001)
J Virol
, vol.75
, Issue.5
, pp. 2224-2234
-
-
Cho, M.W.1
Kim, Y.B.2
Lee, M.K.3
-
12
-
-
0033952103
-
Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian-human immunodeficiency virus infection
-
Baba TW, Liska V, Hofmann-Lehmann R, et al.: Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian-human immunodeficiency virus infection. Nat Med 2000;6(2):200-206.
-
(2000)
Nat Med
, vol.6
, Issue.2
, pp. 200-206
-
-
Baba, T.W.1
Liska, V.2
Hofmann-Lehmann, R.3
-
13
-
-
0032947286
-
Protection of macaques against pathogenic simian/human immunodeficiency virus 89.6PD by passive transfer of neutralizing antibodies
-
Mascola JR, Lewis MG, Stiegler G, et al.: Protection of macaques against pathogenic simian/human immunodeficiency virus 89.6PD by passive transfer of neutralizing antibodies. J Virol 1999;73(5):4009-4018.
-
(1999)
J Virol
, vol.73
, Issue.5
, pp. 4009-4018
-
-
Mascola, J.R.1
Lewis, M.G.2
Stiegler, G.3
-
14
-
-
0033951746
-
Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies
-
Mascola JR, Stiegler G, VanCott TC, et al.: Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies. Nat Med 2000;6(2):207-210.
-
(2000)
Nat Med
, vol.6
, Issue.2
, pp. 207-210
-
-
Mascola, J.R.1
Stiegler, G.2
Vancott, T.C.3
-
15
-
-
0036170921
-
Determination of a statistically valid neutralization titer in plasma that confers protection against simian-human immunodeficiency virus challenge following passive transfer of high-titered neutralizing antibodies
-
Nishimura Y, Igarashi T, Haigwood N, et al.: Determination of a statistically valid neutralization titer in plasma that confers protection against simian-human immunodeficiency virus challenge following passive transfer of high-titered neutralizing antibodies. J Virol 2002;76(5):2123-2130.
-
(2002)
J Virol
, vol.76
, Issue.5
, pp. 2123-2130
-
-
Nishimura, Y.1
Igarashi, T.2
Haigwood, N.3
-
16
-
-
0034864776
-
Antibody protects macaques against vaginal challenge with a pathogenic R5 simian/human immunodeficiency virus at serum levels giving complete neutralization in vitro
-
Parren PW, Marx PA, Hessell AJ, et al.: Antibody protects macaques against vaginal challenge with a pathogenic R5 simian/human immunodeficiency virus at serum levels giving complete neutralization in vitro. J Virol 2001;75(17): 8340-8347.
-
(2001)
J Virol
, vol.75
, Issue.17
, pp. 8340-8347
-
-
Parren, P.W.1
Marx, P.A.2
Hessell, A.J.3
-
17
-
-
0032907674
-
Neutralizing antibody directed against the HIV-1 envelope glycoprotein can completely block HIV-1/SIV chimeric virus infections of macaque monkeys
-
Shibata R, Igarashi T, Haigwood N, et al.: Neutralizing antibody directed against the HIV-1 envelope glycoprotein can completely block HIV-1/SIV chimeric virus infections of macaque monkeys. Nat Med 1999;5(2):204-210.
-
(1999)
Nat Med
, vol.5
, Issue.2
, pp. 204-210
-
-
Shibata, R.1
Igarashi, T.2
Haigwood, N.3
-
18
-
-
38349081511
-
The challenges of eliciting neutralizing antibodies to HIV-1 and to influenza virus
-
Karlsson-Hedestam GB, Fouchier RA, Phogat S, Burton DR, Sodroski J, and Wyatt RT: The challenges of eliciting neutralizing antibodies to HIV-1 and to influenza virus. Nat Rev Microbiol 2008;6(2):143-155.
-
(2008)
Nat Rev Microbiol
, vol.6
, Issue.2
, pp. 143-155
-
-
Karlsson-Hedestam, G.B.1
Fouchier, R.A.2
Phogat, S.3
Burton, D.R.4
Sodroski, J.5
Wyatt, R.T.6
-
19
-
-
29444442970
-
Neutralizing antibody responses drive the evolution of human immunodeficiency virus type 1 envelope during recent HIV infection
-
Frost SD, Wrin T, Smith DM, et al.: Neutralizing antibody responses drive the evolution of human immunodeficiency virus type 1 envelope during recent HIV infection. Proc Natl Acad Sci USA 2005;102(51):18514-18519.
-
(2005)
Proc Natl Acad Sci USA
, vol.102
, Issue.51
, pp. 18514-18519
-
-
Frost, S.D.1
Wrin, T.2
Smith, D.M.3
-
20
-
-
0037389643
-
Rapid evolution of the neutralizing antibody response to HIV type 1 infection
-
Richman DD, Wrin T, Little SJ, and Petropoulos CJ: Rapid evolution of the neutralizing antibody response to HIV type 1 infection. Proc Natl Acad Sci USA 2003;100(7):4144-4149.
-
(2003)
Proc Natl Acad Sci USA
, vol.100
, Issue.7
, pp. 4144-4149
-
-
Richman, D.D.1
Wrin, T.2
Little, S.J.3
Petropoulos, C.J.4
-
21
-
-
0037456827
-
Antibody neutralization and escape by HIV-1
-
Wei X, Decker JM, Wang S, et al.: Antibody neutralization and escape by HIV-1. Nature 2003;422(6929):307-312.
-
(2003)
Nature
, vol.422
, Issue.6929
, pp. 307-312
-
-
Wei, X.1
Decker, J.M.2
Wang, S.3
-
22
-
-
1542317452
-
HIV vaccine design and the neutralizing antibody problem
-
Burton DR, Desrosiers RC, Doms RW, et al.: HIV vaccine design and the neutralizing antibody problem. Nat Immunol 2004;5(3):233-236.
-
(2004)
Nat Immunol
, vol.5
, Issue.3
, pp. 233-236
-
-
Burton, D.R.1
Desrosiers, R.C.2
Doms, R.W.3
-
23
-
-
34948854718
-
Broad HIV-1 neutralization mediated by CD4-binding site antibodies
-
Li Y, Migueles SA, Welcher B, et al.: Broad HIV-1 neutralization mediated by CD4-binding site antibodies. Nat Med 2007;13(9):1032-1034.
-
(2007)
Nat Med
, vol.13
, Issue.9
, pp. 1032-1034
-
-
Li, Y.1
Migueles, S.A.2
Welcher, B.3
-
24
-
-
63849131879
-
Broad diversity of neutralizing antibodies isolated from memory B cells in HIV-infected individuals
-
Scheid JF, Mouquet H, Feldhahn N, et al.: Broad diversity of neutralizing antibodies isolated from memory B cells in HIV-infected individuals. Nature 2009;458(7238):636-640.
-
(2009)
Nature
, vol.458
, Issue.7238
, pp. 636-640
-
-
Scheid, J.F.1
Mouquet, H.2
Feldhahn, N.3
-
25
-
-
43249120051
-
Cross-clade neutralization patterns among HIV-1 strains from the six major clades of the pandemic evaluated and compared in two different models
-
Brown BK, Wieczorek L, Sanders-Buell E, et al.: Cross-clade neutralization patterns among HIV-1 strains from the six major clades of the pandemic evaluated and compared in two different models. Virology 2008;375(2):529-538.
-
(2008)
Virology
, vol.375
, Issue.2
, pp. 529-538
-
-
Brown, B.K.1
Wieczorek, L.2
Sanders-Buell, E.3
-
26
-
-
0027985431
-
Efficient neutralization of primary isolates of HIV-1 by a recombinant human monoclonal antibody
-
Burton DR, Pyati J, Koduri R, et al.: Efficient neutralization of primary isolates of HIV-1 by a recombinant human monoclonal antibody. Science 1994;266(5187):1024-1027.
-
(1994)
Science
, vol.266
, Issue.5187
, pp. 1024-1027
-
-
Burton, D.R.1
Pyati, J.2
Koduri, R.3
-
27
-
-
23244434512
-
Human immunodeficiency virus type 1 env clones from acute and early subtype B infections for standardized assessments of vaccine-elicited neutralizing antibodies
-
Li M, Gao F, Mascola JR, et al.: Human immunodeficiency virus type 1 env clones from acute and early subtype B infections for standardized assessments of vaccine-elicited neutralizing antibodies. J Virol 2005;79(16):10108-10125.
-
(2005)
J Virol
, vol.79
, Issue.16
, pp. 10108-10125
-
-
Li, M.1
Gao, F.2
Mascola, J.R.3
-
28
-
-
43249120426
-
Recent advances in the characterization of HIV-1 neutralization assays for standardized evaluation of the antibody response to infection and vaccination
-
Polonis VR, Brown BK, Rosa Borges A, et al.: Recent advances in the characterization of HIV-1 neutralization assays for standardized evaluation of the antibody response to infection and vaccination. Virology 2008;375(2):315-320.
-
(2008)
Virology
, vol.375
, Issue.2
, pp. 315-320
-
-
Polonis, V.R.1
Brown, B.K.2
Rosa Borges, A.3
-
29
-
-
0029815226
-
Differential glycosylation, virion incorporation, and sensitivity to neutralizing antibodies of human immunodeficiency virus type1 envelopeproducedfrominfectedprimaryT-lymphocyte and macrophage cultures
-
Willey RL, Shibata R, Freed EO, Cho MW, and Martin MA: Differential glycosylation, virion incorporation, and sensitivity to neutralizing antibodies of human immunodeficiency virus type1 envelopeproducedfrominfectedprimaryT- lymphocyte and macrophage cultures. J Virol 1996;70(9):6431-6436.
-
(1996)
J Virol
, vol.70
, Issue.9
, pp. 6431-6436
-
-
Willey, R.L.1
Shibata, R.2
Freed, E.O.3
Cho, M.W.4
Martin, M.A.5
-
30
-
-
0029951823
-
Vaccine protection by a triple deletion mutant of simian immunodeficiency virus
-
Wyand MS, Manson KH, Garcia-Moll M, Montefiori D, and Desrosiers RC: Vaccine protection by a triple deletion mutant of simian immunodeficiency virus. J Virol 1996;70(6): 3724-3733.
-
(1996)
J Virol
, vol.70
, Issue.6
, pp. 3724-3733
-
-
Wyand, M.S.1
Manson, K.H.2
Garcia-Moll, M.3
Montefiori, D.4
Desrosiers, R.C.5
-
31
-
-
33745158157
-
A simple method of estimating fifty percent endpoints
-
Reed LJ and Muench H: A simple method of estimating fifty percent endpoints. Am J Hyg 1938;27:493-497.
-
(1938)
Am J Hyg
, vol.27
, pp. 493-497
-
-
Reed, L.J.1
Muench, H.2
-
32
-
-
0030855058
-
Infection and pathogenicity of chimeric simian-human immunodeficiency viruses in macaques: Determinants of high virus loads and CD4 cell killing
-
Shibata R, Maldarelli F, Siemon C, et al.: Infection and pathogenicity of chimeric simian-human immunodeficiency viruses in macaques: Determinants of high virus loads and CD4 cell killing. J Infect Dis 1997;176(2):362-373.
-
(1997)
J Infect Dis
, vol.176
, Issue.2
, pp. 362-373
-
-
Shibata, R.1
Maldarelli, F.2
Siemon, C.3
-
33
-
-
0029018332
-
Isolation and characterization of a syncytium-inducing, macrophage/ T-cell line-tropic human immunodeficiency virus type 1 isolate that readily infects chimpanzee cells in vitro and in vivo
-
Shibata R, Hoggan MD, Broscius C, et al.: Isolation and characterization of a syncytium-inducing, macrophage/ T-cell line-tropic human immunodeficiency virus type 1 isolate that readily infects chimpanzee cells in vitro and in vivo. J Virol 1995;69(7):4453-4462.
-
(1995)
J Virol
, vol.69
, Issue.7
, pp. 4453-4462
-
-
Shibata, R.1
Hoggan, M.D.2
Broscius, C.3
-
34
-
-
0004116672
-
-
3d ed. Cambridge University Press, Cambridge, England
-
Finney DJ: Probit Analysis, 3d ed. Cambridge University Press, Cambridge, England, 2007.
-
(2007)
Probit Analysis
-
-
Finney, D.J.1
-
36
-
-
56449131391
-
Profiling the specificity of neutralizing antibodies in a large panel of plasmas from patients chronically infected with human immunodeficiency virus type 1 subtypes B and C
-
Binley JM, Lybarger EA, Crooks ET, et al.: Profiling the specificity of neutralizing antibodies in a large panel of plasmas from patients chronically infected with human immunodeficiency virus type 1 subtypes B and C. J Virol 2008;82(23):11651-11668.
-
(2008)
J Virol
, vol.82
, Issue.23
, pp. 11651-11668
-
-
Binley, J.M.1
Lybarger, E.A.2
Crooks, E.T.3
-
37
-
-
34249952292
-
Macaques infected with a CCR5-tropic simian/human immunodeficiency virus (SHIV) develop broadly reactive anti-HIV neutralizing antibodies
-
Kraft Z, Derby NR, McCaffrey RA, et al.: Macaques infected with a CCR5-tropic simian/human immunodeficiency virus (SHIV) develop broadly reactive anti-HIV neutralizing antibodies. J Virol 2007;81(12):6402-6411.
-
(2007)
J Virol
, vol.81
, Issue.12
, pp. 6402-6411
-
-
Kraft, Z.1
Derby, N.R.2
McCaffrey, R.A.3
-
38
-
-
58149487629
-
Human immunodeficiency virus type 1 env trimer immunization of macaques and impact of priming with viral vector or stabilized core protein
-
Morner A, Douagi I, Forsell MN, et al.: Human immunodeficiency virus type 1 env trimer immunization of macaques and impact of priming with viral vector or stabilized core protein. J Virol 2009;83(2):540-551.
-
(2009)
J Virol
, vol.83
, Issue.2
, pp. 540-551
-
-
Morner, A.1
Douagi, I.2
Forsell, M.N.3
-
39
-
-
23844467017
-
HIV-1 envelope pseudo typed viral vectors and infectious molecular clones expressing the same envelope glycoprotein have a similar neutralization phenotype, but culture in peripheral blood mononuclear cells is associated with decreased neutralization sensitivity
-
Louder MK, Sambor A, Chertova E, et al.: HIV-1 envelope pseudotyped viral vectors and infectious molecular clones expressing the same envelope glycoprotein have a similar neutralization phenotype, but culture in peripheral blood mononuclear cells is associated with decreased neutralization sensitivity. Virology 2005;339(2):226-238.
-
(2005)
Virology
, vol.339
, Issue.2
, pp. 226-238
-
-
Louder, M.K.1
Sambor, A.2
Chertova, E.3
-
40
-
-
69449087173
-
HIV sensitivity to neutralization is determined by target and virus producer cell properties
-
Mann AM, Rusert P, Berlinger L, Kuster H, Gunthard HF, and Trkola A: HIV sensitivity to neutralization is determined by target and virus producer cell properties. AIDS 2009;23(13):1659-1667.
-
(2009)
AIDS
, vol.23
, Issue.13
, pp. 1659-1667
-
-
Mann, A.M.1
Rusert, P.2
Berlinger, L.3
Kuster, H.4
Gunthard, H.F.5
Trkola, A.6
-
41
-
-
0034958413
-
Antibody from patients with acute human immunodeficiency virus (HIV) infection inhibits primary strains of HIV type 1 in the presence of natural-killer effector cells
-
Forthal DN, Landucci G, and Daar ES: Antibody from patients with acute human immunodeficiency virus (HIV) infection inhibits primary strains of HIV type 1 in the presence of natural-killer effector cells. J Virol 2001;75(15):6953-6961.
-
(2001)
J Virol
, vol.75
, Issue.15
, pp. 6953-6961
-
-
Forthal, D.N.1
Landucci, G.2
Daar, E.S.3
-
42
-
-
0033375327
-
Antibody dependent cellular cytotoxicity independently predicts survival in severely immuno compromised human immunodeficiency virus-infected patients
-
Forthal DN, Landucci G, Haubrich R, et al.: Antibodydependent cellular cytotoxicity independently predicts survival in severely immunocompromised human immunodeficiency virus-infected patients. J Infect Dis 1999; 180(4):1338-1341.
-
(1999)
J Infect Dis
, vol.180
, Issue.4
, pp. 1338-1341
-
-
Forthal, D.N.1
Landucci, G.2
Haubrich, R.3
-
43
-
-
13544277161
-
Vaccine elicited antibodies mediate antibody-dependent cellular cytotoxicity correlated with significantly reduced acute viremia in rhesus macaques challenged with SIVmac251
-
Gomez-Roman VR, Patterson LJ, Venzon D, et al.: Vaccineelicited antibodies mediate antibody-dependent cellular cytotoxicity correlated with significantly reduced acute viremia in rhesus macaques challenged with SIVmac251. J Immunol 2005;174(4):2185-2189.
-
(2005)
J Immunol
, vol.174
, Issue.4
, pp. 2185-2189
-
-
Gomez-Roman, V.R.1
Patterson, L.J.2
Venzon, D.3
-
44
-
-
34548496893
-
Fc receptor but not complement binding is important in antibody protection against HIV
-
Hessell AJ, Hangartner L, Hunter M, et al.: Fc receptor but not complement binding is important in antibody protection against HIV. Nature 2007;449(7158):101-104.
-
(2007)
Nature
, vol.449
, Issue.7158
, pp. 101-104
-
-
Hessell, A.J.1
Hangartner, L.2
Hunter, M.3
-
45
-
-
57349169315
-
Human immunodeficiency virus type 1 super infection occurs despite relatively robust neutralizing antibody responses
-
Blish CA, Dogan OC, Derby NR, et al.: Human immunodeficiency virus type 1 superinfection occurs despite relatively robust neutralizing antibody responses. J Virol 2008;82(24): 12094-12103.
-
(2008)
J Virol
, vol.82
, Issue.24
, pp. 12094-12103
-
-
Blish, C.A.1
Dogan, O.C.2
Derby, N.R.3
-
46
-
-
38349147390
-
In vivo efficacy of human immunodeficiency virus neutralizing antibodies: Estimates for protective titers
-
Trkola A, Kuster H, Rusert P, et al.: In vivo efficacy of human immunodeficiency virus neutralizing antibodies: Estimates for protective titers. J Virol 2008;82(3):1591-1599.
-
(2008)
J Virol
, vol.82
, Issue.3
, pp. 1591-1599
-
-
Trkola, A.1
Kuster, H.2
Rusert, P.3
|